HK2 and glioblastoma: Notably, the intensity of COL5A1-positive staining and the number of cells showing subcellular co-localization of COL5A1 and NOX2 or HK2 were significantly elevated in in patients with GBM (G4) relative to that in patients with G3 glioma (G3) (Figure 6c–e).